Veterinary Medicines

CEFTIONEL-50, 50 mg/ml injekcinė suspensija galvijams ir kiaulėms

Authorised
  • Ceftiofur
Download as PDF

Product identification

Medicine name:
CEFTIONEL-50, 50 mg/ml injekcinė suspensija galvijams ir kiaulėms
Active substance:
  • Ceftiofur
Target species:
  • Cattle
  • Pig
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Ceftiofur
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        5
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DD90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Interchemie werken De Adelaar LT UAB
Marketing authorisation date:
Manufacturing sites for batch release:
  • Interchemie Werken De Adelaar Eesti AS
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/10/2002/001-002
Date of authorisation status change:

Documents

RV2002.pdf

Lithuanian (PDF)
Published on: 25/11/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."